biguanides has been researched along with Invasiveness, Neoplasm in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herrera-Martínez, AD | 1 |
Pedraza-Arevalo, S | 1 |
L-López, F | 1 |
Gahete, MD | 1 |
Gálvez-Moreno, MA | 1 |
Castaño, JP | 1 |
Luque, RM | 1 |
Shepard, JB | 1 |
Wilkinson, RA | 1 |
Starkey, JR | 1 |
Teintze, M | 1 |
2 other studies available for biguanides and Invasiveness, Neoplasm
Article | Year |
---|---|
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
Topics: Adult; Aged; Apoptosis; Biguanides; Carcinoid Tumor; Cell Line, Tumor; Cell Movement; Cell Prolifera | 2019 |
Novel guanide-substituted compounds bind to CXCR4 and inhibit breast cancer metastasis.
Topics: Animals; Biguanides; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Dogs; Drug Screening Assa | 2014 |